छोड़कर सामग्री पर जाएँ

Latest News

Gainers  Losers: 10 stocks that moved the most on January 18

Gainers Losers: 10 stocks that moved the most on January 18

On the sectoral front, metal index added 2 percent and capital goods index rose 1 percent, while bank and pharma indices added 0.5 percent each. The BSE midcap and smallcap indices ended with marginal gains

Read More

​ On the sectoral front, metal index added 2 percent and capital goods index rose 1 percent, while bank and pharma indices added 0.5 percent each. The BSE midcap and smallcap indices ended with marginal gains On the sectoral front, metal index added 2 percent and capital goods index rose 1 percent, while bank and pharma indices added 0.5 percent each. The BSE midcap and smallcap indices ended with marginal gains  Moneycontrol Latest News Read More  

On the sectoral front, metal index added 2 percent and capital goods index rose 1 percent, while bank and pharma indices added 0.5 percent each. The BSE midcap and smallcap indices ended with marginal gains

Moneycontrol Pro Panorama | What#39;s driving optimism at Davos 2023

Moneycontrol Pro Panorama | What#39;s driving optimism at Davos 2023

In today’s edition of Moneycontrol Pro Panorama: China losing its edge, India#39;s import export stands on firm ground, FMCG stocks face major headwinds, steps that can aid auto sector, and more

Read More

​ In today’s edition of Moneycontrol Pro Panorama: China losing its edge, India#39;s import export stands on firm ground, FMCG stocks face major headwinds, steps that can aid auto sector, and more In today’s edition of Moneycontrol Pro Panorama: China losing its edge, India#39;s import export stands on firm ground, FMCG stocks face major headwinds, steps that can aid auto sector, and more  Moneycontrol Latest News Read More  

In today’s edition of Moneycontrol Pro Panorama: China losing its edge, India#39;s import export stands on firm ground, FMCG stocks face major headwinds, steps that can aid auto sector, and more

Buy ICICI Lombard; target of Rs 1500: Motilal Oswal

Buy ICICI Lombard; target of Rs 1500: Motilal Oswal

Motilal Oswal is bullish on ICICI Lombard recommended buy rating on the stock with a target price of Rs 1500 in its research report dated January 17, 2023.

Read More

​ Motilal Oswal is bullish on ICICI Lombard recommended buy rating on the stock with a target price of Rs 1500 in its research report dated January 17, 2023. Motilal Oswal is bullish on ICICI Lombard recommended buy rating on the stock with a target price of Rs 1500 in its research report dated January 17, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on ICICI Lombard recommended buy rating on the stock with a target price of Rs 1500 in its research report dated January 17, 2023.

Buy ANGEL One; target of Rs 2100: Motilal Oswal

Buy ANGEL One; target of Rs 2100: Motilal Oswal

Motilal Oswal is bullish on ANGEL One recommended buy rating on the stock with a target price of Rs 2100 in its research report dated January 17, 2023.

Read More

​ Motilal Oswal is bullish on ANGEL One recommended buy rating on the stock with a target price of Rs 2100 in its research report dated January 17, 2023. Motilal Oswal is bullish on ANGEL One recommended buy rating on the stock with a target price of Rs 2100 in its research report dated January 17, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on ANGEL One recommended buy rating on the stock with a target price of Rs 2100 in its research report dated January 17, 2023.

Eris Lifesciences falls as margins contract; derma brands#39; acquisition fails to cheer Street

Eris Lifesciences falls as margins contract; derma brands#39; acquisition fails to cheer Street

Eris Lifesciences announced acquisition of nine dermatology brands from Glenmark Pharma for Rs 340 crore. The brands include Onabet, Halobate, Sorvate, and Demelan for India and Nepal.

Read More

​ Eris Lifesciences announced acquisition of nine dermatology brands from Glenmark Pharma for Rs 340 crore. The brands include Onabet, Halobate, Sorvate, and Demelan for India and Nepal. Eris Lifesciences announced acquisition of nine dermatology brands from Glenmark Pharma for Rs 340 crore. The brands include Onabet, Halobate, Sorvate, and Demelan for India and Nepal.  Moneycontrol Latest News Read More  

Eris Lifesciences announced acquisition of nine dermatology brands from Glenmark Pharma for Rs 340 crore. The brands include Onabet, Halobate, Sorvate, and Demelan for India and Nepal.

President Ferdinand Marcos Jr sees Philippine economy growing around 7% this year

President Ferdinand Marcos Jr sees Philippine economy growing around 7% this year

The Southeast Asian country, which will announce its 2022 economic performance on Jan. 26, also expects last year#39;s gross domestic product growth to be faster than the 6.5%-7.5% target.

Read More

​ The Southeast Asian country, which will announce its 2022 economic performance on Jan. 26, also expects last year#39;s gross domestic product growth to be faster than the 6.5%-7.5% target. The Southeast Asian country, which will announce its 2022 economic performance on Jan. 26, also expects last year#39;s gross domestic product growth to be faster than the 6.5%-7.5% target.  Moneycontrol Latest News Read More  

The Southeast Asian country, which will announce its 2022 economic performance on Jan. 26, also expects last year#39;s gross domestic product growth to be faster than the 6.5%-7.5% target.

After green bond issuance, India should consider its own Green New Deal

After green bond issuance, India should consider its own Green New Deal

The thinking behind the green bond issuance is to seek out international investors, who give climate change mitigation a priority and help India achieve its climate change targets

Read More

​ The thinking behind the green bond issuance is to seek out international investors, who give climate change mitigation a priority and help India achieve its climate change targets The thinking behind the green bond issuance is to seek out international investors, who give climate change mitigation a priority and help India achieve its climate change targets  Moneycontrol Latest News Read More  

The thinking behind the green bond issuance is to seek out international investors, who give climate change mitigation a priority and help India achieve its climate change targets

Landmark Cars zooms 7% to record high on 41% rise in 9-month proforma revenue

Landmark Cars zooms 7% to record high on 41% rise in 9-month proforma revenue

The luxury car retailer clocked 41.3 percent year-on-year growth in proforma revenue at Rs 3,384 crore for nine-month period ended December FY23 (9MFY23).

Read More

​ The luxury car retailer clocked 41.3 percent year-on-year growth in proforma revenue at Rs 3,384 crore for nine-month period ended December FY23 (9MFY23). The luxury car retailer clocked 41.3 percent year-on-year growth in proforma revenue at Rs 3,384 crore for nine-month period ended December FY23 (9MFY23).  Moneycontrol Latest News Read More  

The luxury car retailer clocked 41.3 percent year-on-year growth in proforma revenue at Rs 3,384 crore for nine-month period ended December FY23 (9MFY23).

Karnataka court orders status quo of ED-attached Mantri Serenity flats

Karnataka court orders status quo of ED-attached Mantri Serenity flats

This comes after the enforcement directorate seized 381 apartments worth Rs 285 crore in the delayed south Bengaluru project.

Read More

​ This comes after the enforcement directorate seized 381 apartments worth Rs 285 crore in the delayed south Bengaluru project. This comes after the enforcement directorate seized 381 apartments worth Rs 285 crore in the delayed south Bengaluru project.  Moneycontrol Latest News Read More  

This comes after the enforcement directorate seized 381 apartments worth Rs 285 crore in the delayed south Bengaluru project.

Buy Newgen Software; target of Rs 460: ICICI Direct

Buy Newgen Software; target of Rs 460: ICICI Direct

ICICI Direct is bullish on Newgen Software recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 18, 2023.

Read More

​ ICICI Direct is bullish on Newgen Software recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 18, 2023. ICICI Direct is bullish on Newgen Software recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 18, 2023.  Moneycontrol Latest News Read More  

ICICI Direct is bullish on Newgen Software recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 18, 2023.

hi_INहिन्दी